ahlam1399
06-12-2015, 12:32 AM
UPDATE 1-FDA panel backs approval of GSK asthma drug in adults
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/472887e7/sc/19/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/1/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/1/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/2/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/2/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/3/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/ach.img (http://adchoice.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/ach.htm)http://pi.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2t.imghttp://pi2.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=FhW42vqBvR0:v-JyQGI6nNQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=FhW42vqBvR0:v-JyQGI6nNQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/FhW42vqBvR0
June 11 (Reuters) - An advisory committee to the U.S. Food and Drug Administration recommended approval on Thursday of GlaxoSmithKline Plc's drug mepolizumab for severe asthma in patients aged 18 and older.http://i1.wp.com/reuters.us.feedsportal.com/c/35217/f/654213/s/472887e7/sc/19/mf.gif?resize=1%2C1
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/1/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/1/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/2/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/2/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/3/rc.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/rc/3/rc.htm)
http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2.img (http://da.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2.htm)
http://adchoice.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/ach.img (http://adchoice.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/ach.htm)http://pi.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2t.imghttp://pi2.feedsportal.com/r/231041688583/u/49/f/654213/c/35217/s/472887e7/sc/19/a2t2.imghttp://feeds.feedburner.com/~ff/reuters/companyNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/companyNews?i=FhW42vqBvR0:v-JyQGI6nNQ:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:V_sGLiPBpWU) http://feeds.feedburner.com/~ff/reuters/companyNews?i=FhW42vqBvR0:v-JyQGI6nNQ:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/companyNews?a=FhW42vqBvR0:v-JyQGI6nNQ:F7zBnMyn0Lo)
http://feeds.feedburner.com/~r/reuters/companyNews/~4/FhW42vqBvR0